A study by Gattelli and colleagues determined that RET activation promotes growth, proliferation, and migration of ER+ breast cancer cells in vitro and in vivo (144), strongly suggesting that RET is actionable in ER+ breast cancers. The gene discussed is RET; the disease is breast carcinoma.